ACCF/AHA clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents and the American Heart Association endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.
Holmes
David R
DR
Dehmer
Gregory J
GJ
Kaul
Sanjay
S
Leifer
Dana
D
O'Gara
Patrick T
PT
Stein
C Michael
CM
D026683:Advisory Committees / Q000592:standards*; D000572:American Heart Association; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics / Q000378:metabolism; D002309:Cardiology / Q000592:standards; D000077144:Clopidogrel; D017023:Coronary Angiography / Q000592:standards; D065731:Cytochrome P-450 CYP2C19; D004348:Drug Labeling / Q000379:methods / Q000592:standards*; D005582:Foundations / Q000592:standards; D006801:Humans; D012955:Societies, Medical / Q000592:standards*; D013903:Thoracic Surgery / Q000592:standards; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism; D014481:United States; D014486:United States Food and Drug Administration / Q000592:standards
D000077144:Clopidogrel; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19; D013988:Ticlopidine